929 related articles for article (PubMed ID: 11169322)
1. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
[TBL] [Abstract][Full Text] [Related]
2. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
; Prabhu M; Kuller JA; Biggio JR
Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
[TBL] [Abstract][Full Text] [Related]
3. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
4. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
[TBL] [Abstract][Full Text] [Related]
5. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry.
Verdin SM; Economides DL
Br J Obstet Gynaecol; 1998 Jan; 105(1):63-7. PubMed ID: 9442164
[TBL] [Abstract][Full Text] [Related]
6. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
7. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
[TBL] [Abstract][Full Text] [Related]
8. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of fetal nuchal translucency.
Jackson M; Rose NC
Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
[TBL] [Abstract][Full Text] [Related]
10. First-trimester nuchal edema as a marker of aneuploidy.
Comas C; Martinez JM; Ojuel J; Casals E; Puerto B; Borrell A; Fortuny A
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):26-9. PubMed ID: 7850585
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of ultrasound markers in screening fetal trisomy 21].
Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
[TBL] [Abstract][Full Text] [Related]
12. Second-trimester genetic sonogram for detection of fetal chromosomal abnormalities in a community-based antenatal testing unit.
Bottalico JN; Chen X; Tartaglia M; Rosario B; Yarabothu D; Nelson L
Ultrasound Obstet Gynecol; 2009 Feb; 33(2):161-8. PubMed ID: 19173242
[TBL] [Abstract][Full Text] [Related]
13. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
14. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
[TBL] [Abstract][Full Text] [Related]
15. The significance of choroid plexus cysts, echogenic heart foci and renal pyelectasis in the first trimester.
Whitlow BJ; Lazanakis ML; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 1998 Dec; 12(6):385-90. PubMed ID: 9918086
[TBL] [Abstract][Full Text] [Related]
16. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
[TBL] [Abstract][Full Text] [Related]
17. The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's syndrome.
Michailidis GD; Spencer K; Economides DL
BJOG; 2001 Oct; 108(10):1047-52. PubMed ID: 11702836
[TBL] [Abstract][Full Text] [Related]
18. Screening for fetal anomalies by ultrasound at 14 and 21 weeks.
D'Ottavio G; Meir YJ; Rustico MA; Pecile V; Fischer-Tamaro L; Conoscenti G; Natale R; Mandruzzato GP
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):375-80. PubMed ID: 9476319
[TBL] [Abstract][Full Text] [Related]
19. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
[TBL] [Abstract][Full Text] [Related]
20. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
